Northwestern Mutual Wealth Management CO Cue Biopharma, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $147 Billion
- Q3 2025
A detailed history of Northwestern Mutual Wealth Management CO transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 79,500 shares of CUE stock, worth $50,085. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,500
Previous 83,000
4.22%
Holding current value
$50,085
Previous $56,000
1.79%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding CUE
# of Institutions
53Shares Held
18.4MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY6.82MShares$4.3 Million1.28% of portfolio
-
Catalytic Wealth Ria, LLC Cambridge, MA3.43MShares$2.16 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.04MShares$1.91 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA801KShares$504,4830.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$476,7430.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $22.3M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...